Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
Aglietta M, Barkholt L, Schianca FC, Caravelli D, Omazic B, Minotto C, Leone F, Hentschke P, Bertoldero G, Capaldi A, Ciccone G, Niederwieser D, Ringdén O, Demirer T; EBMT Solid Tumor Working Party. Aglietta M, et al. Among authors: barkholt l. Biol Blood Marrow Transplant. 2009 Mar;15(3):326-35. doi: 10.1016/j.bbmt.2008.11.036. Biol Blood Marrow Transplant. 2009. PMID: 19203723 Free article. Clinical Trial.
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe.
Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, Massenkeil G, Pedrazzoli P, Zambelli A, Bay JO, Francois S, Martino R, Bengala C, Brune M, Lenhoff S, Porcellini A, Falda M, Siena S, Demirer T, Niederwieser D, Ringdén O; French ITAC group and the EBMT Solid Tumour Working Party. Barkholt L, et al. Ann Oncol. 2006 Jul;17(7):1134-40. doi: 10.1093/annonc/mdl086. Epub 2006 Apr 28. Ann Oncol. 2006. PMID: 16648196 Free article. Clinical Trial.
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
Peccatori J, Barkholt L, Demirer T, Sormani MP, Bruzzi P, Ciceri F, Zambelli A, Da Prada GA, Pedrazzoli P, Siena S, Massenkeil G, Martino R, Lenhoff S, Corradini P, Rosti G, Ringden O, Bregni M, Niederwieser D; European Bone Marrow Transplantation Solid Tumor Working Party. Peccatori J, et al. Among authors: barkholt l. Cancer. 2005 Nov 15;104(10):2099-103. doi: 10.1002/cncr.21477. Cancer. 2005. PMID: 16220555 Free article.
Current immunotherapy for solid tumors.
Barkholt L, Bregni M. Barkholt L, et al. Immunotherapy. 2009 May;1(3):483-93. doi: 10.2217/imt.09.13. Immunotherapy. 2009. PMID: 20635964 Review.
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.
Crocchiolo R, Ringden O, Bay JO, Blaise D, Omasic B, Mazzi B, Picard C, Trinca S, Barkholt L, Peccatori J, Gregori S, Amodio G, Fleischhauer K, Ciceri F, Bregni M. Crocchiolo R, et al. Among authors: barkholt l. Bone Marrow Transplant. 2018 Feb;53(2):213-218. doi: 10.1038/bmt.2017.243. Epub 2017 Nov 13. Bone Marrow Transplant. 2018. PMID: 29131154
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Barkholt L, Hentschke P, Zetterquist H, Mattsson J, Uzunel M, Wersäll P, Martola J, Albin N, Aschan J, Wijkström H, Tillegård A, Oman S, Wernerson A, Niederwieser D, Thörne A, Ringdén O. Barkholt L, et al. Transplant Proc. 2001 Feb-Mar;33(1-2):1862-4. doi: 10.1016/s0041-1345(00)02726-3. Transplant Proc. 2001. PMID: 11267544 No abstract available.
84 results